NPI: 1801857172 · EAST MEADOW, NY 11554 · General Acute Care Hospital · NPI assigned 03/28/2006
Authorized official MILLER, RICHARD controls 20+ related entities in our dataset. Read more
| Authorized Official | MILLER, RICHARD (CHIEF FINANCIAL OFFICER) |
| NPI Enumeration Date | 03/28/2006 |
Other providers sharing the same authorized official: MILLER, RICHARD
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 12,633 | $623K |
| 2019 | 71,647 | $2.93M |
| 2020 | 145,774 | $6.24M |
| 2021 | 172,860 | $8.21M |
| 2022 | 169,234 | $8.71M |
| 2023 | 174,420 | $8.94M |
| 2024 | 119,061 | $6.51M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 47,472 | 40,958 | $6.60M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 66,574 | 55,855 | $6.03M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 29,863 | 24,606 | $3.08M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 18,988 | 17,788 | $2.88M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12,944 | 12,299 | $1.95M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 10,285 | 9,512 | $1.42M |
| 90834 | Psychotherapy, 45 minutes with patient | 11,338 | 4,839 | $1.41M |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 10,181 | 9,836 | $1.16M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 10,382 | 8,723 | $891K |
| G0378 | Hospital observation service, per hour | 1,004 | 976 | $736K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 11,513 | 10,147 | $719K |
| 96361 | Intravenous infusion, hydration; each additional hour | 4,203 | 3,467 | $639K |
| 70450 | Computed tomography, head or brain; without contrast material | 4,044 | 3,870 | $589K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 6,754 | 5,545 | $588K |
| 80053 | Comprehensive metabolic panel | 32,220 | 26,919 | $527K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3,474 | 3,372 | $455K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 4,719 | 4,150 | $435K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 7,605 | 2,518 | $400K |
| 99443 | 5,571 | 4,914 | $385K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 3,492 | 3,416 | $344K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 3,096 | 3,068 | $339K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 6,527 | 2,153 | $315K |
| 90832 | Psychotherapy, 30 minutes with patient | 3,225 | 1,773 | $314K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 512 | 511 | $310K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 3,859 | 3,343 | $306K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 1,204 | 1,176 | $286K |
| 90792 | Psychiatric diagnostic evaluation with medical services | 1,511 | 1,381 | $272K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1,688 | 1,604 | $263K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1,478 | 1,450 | $260K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 564 | 317 | $253K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 7,838 | 7,410 | $227K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 2,935 | 2,890 | $219K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1,578 | 1,504 | $219K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4,091 | 3,514 | $216K |
| 92551 | 4,844 | 4,756 | $214K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 2,462 | 2,394 | $205K |
| 41899 | Unlisted procedure, dentoalveolar structures | 255 | 246 | $203K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4,531 | 4,492 | $198K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 2,019 | 1,956 | $182K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2,355 | 2,349 | $178K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 2,325 | 1,894 | $174K |
| 90671 | 921 | 920 | $164K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 239 | 239 | $148K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 5,397 | 5,351 | $126K |
| 80061 | Lipid panel | 12,676 | 12,179 | $125K |
| 90651 | 1,009 | 1,001 | $119K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 4,792 | 4,687 | $114K |
| 86850 | 4,398 | 4,167 | $107K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 3,093 | 2,574 | $103K |
| 80050 | General health panel | 5,323 | 5,232 | $97K |
| D7140 | Extraction, erupted tooth or exposed root | 2,006 | 1,964 | $95K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 10,615 | 10,355 | $93K |
| 92201 | 1,657 | 1,650 | $93K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2,606 | 2,175 | $92K |
| 90670 | 3,405 | 3,389 | $91K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1,346 | 1,343 | $91K |
| Q3014 | Telehealth originating site facility fee | 5,571 | 5,196 | $90K |
| 99442 | 1,426 | 1,324 | $85K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 7,720 | 6,047 | $84K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 11,259 | 9,551 | $80K |
| 82803 | 6,288 | 6,089 | $77K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 4,777 | 4,677 | $75K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 1,798 | 708 | $74K |
| 86901 | 4,411 | 4,178 | $73K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 5,508 | 5,472 | $73K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2,457 | 2,380 | $72K |
| 76801 | 861 | 731 | $71K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | 1,622 | 738 | $65K |
| 99173 | 4,510 | 4,499 | $65K | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 4,058 | 1,454 | $64K |
| 86480 | 1,009 | 1,003 | $59K | |
| 87536 | 1,412 | 1,384 | $57K | |
| 86360 | 1,347 | 1,329 | $55K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 729 | 652 | $54K |
| 99232 | Subsequent hospital care, per day, moderate complexity | 960 | 466 | $54K |
| G0008 | Administration of influenza virus vaccine | 4,268 | 4,247 | $53K |
| 86900 | 4,382 | 4,149 | $53K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 81 | 81 | $52K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1,113 | 396 | $52K |
| 90686 | 4,257 | 4,239 | $52K | |
| D0140 | Limited oral evaluation - problem focused | 4,355 | 3,996 | $49K |
| 99215 | Prolong outpt/office vis | 426 | 398 | $49K |
| 95819 | 165 | 164 | $49K | |
| 90715 | 2,218 | 2,148 | $47K | |
| 92550 | 915 | 765 | $47K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 157 | 155 | $46K |
| 87806 | 2,739 | 2,714 | $46K | |
| D0330 | Panoramic radiographic image | 1,563 | 1,530 | $42K |
| 83655 | 3,054 | 3,040 | $42K | |
| 0002A | 1,325 | 1,321 | $42K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 216 | 215 | $41K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 260 | 248 | $36K |
| 97161 | 381 | 375 | $36K | |
| 88142 | 1,571 | 1,562 | $35K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 2,891 | 2,809 | $35K |
| 0001A | 1,277 | 1,275 | $35K | |
| D0150 | Comprehensive oral evaluation - new or established patient | 480 | 206 | $35K |
| 99201 | 494 | 476 | $35K | |
| 85027 | 14,222 | 13,329 | $34K | |
| 83880 | 1,974 | 1,920 | $33K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 314 | 291 | $32K |
| 71045 | Radiologic examination, chest; single view | 7,978 | 7,093 | $31K |
| 92083 | 595 | 584 | $30K | |
| 90381 | 62 | 62 | $30K | |
| 84443 | Thyroid stimulating hormone (TSH) | 7,092 | 6,932 | $29K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1,690 | 1,666 | $29K |
| 76830 | Ultrasound, transvaginal | 445 | 438 | $28K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2,323 | 2,231 | $28K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 251 | 249 | $28K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 285 | 283 | $28K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 680 | 660 | $28K |
| 99000 | 1,237 | 1,198 | $27K | |
| 81025 | 10,906 | 10,321 | $27K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 1,033 | 1,028 | $27K |
| 90681 | 2,337 | 2,329 | $27K | |
| 36415 | Collection of venous blood by venipuncture | 8,343 | 7,712 | $27K |
| 92133 | 766 | 752 | $26K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 1,227 | 1,198 | $25K |
| 92587 | 857 | 819 | $24K | |
| A0429 | Ambulance service, basic life support, emergency transport (bls-emergency) | 170 | 163 | $24K |
| 86780 | 4,828 | 4,740 | $23K | |
| 36406 | 1,134 | 1,012 | $23K | |
| 59025 | Fetal non-stress test | 349 | 207 | $23K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 372 | 311 | $22K |
| 0012A | 719 | 718 | $21K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 17,945 | 16,567 | $21K |
| 70486 | 543 | 537 | $21K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 9,711 | 9,649 | $21K |
| 90837 | Psychotherapy, 53 minutes with patient | 184 | 113 | $21K |
| 90698 | 2,930 | 2,915 | $20K | |
| 90380 | 44 | 44 | $20K | |
| 36000 | 1,092 | 1,078 | $20K | |
| 90633 | 1,551 | 1,550 | $19K | |
| 71046 | Radiologic examination, chest; 2 views | 3,556 | 3,454 | $19K |
| 0011A | 730 | 729 | $18K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 10,333 | 9,392 | $17K |
| 36591 | 607 | 413 | $17K | |
| 74178 | 87 | 86 | $17K | |
| 87631 | 517 | 512 | $16K | |
| 73630 | 1,850 | 1,707 | $16K | |
| 12001 | 41 | 41 | $16K | |
| D7210 | Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth | 392 | 383 | $16K |
| 72125 | Computed tomography, cervical spine; without contrast material | 1,252 | 1,222 | $16K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 814 | 806 | $15K |
| 81003 | 13,799 | 11,401 | $15K | |
| 76770 | 49 | 47 | $14K | |
| A0425 | Ground mileage, per statute mile | 1,511 | 1,461 | $14K |
| 36416 | 704 | 477 | $14K | |
| 86803 | 2,713 | 2,678 | $13K | |
| 76641 | 312 | 310 | $13K | |
| 85730 | 6,098 | 5,912 | $12K | |
| 90744 | 2,008 | 1,999 | $12K | |
| 87340 | 3,532 | 3,481 | $12K | |
| 99441 | 241 | 226 | $12K | |
| 84439 | 2,944 | 2,859 | $12K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 44 | 43 | $11K |
| 80051 | 1,211 | 1,194 | $10K | |
| 73610 | 1,528 | 1,405 | $10K | |
| 90710 | 1,283 | 1,281 | $10K | |
| 97010 | 1,443 | 546 | $10K | |
| 59430 | 80 | 78 | $10K | |
| 85610 | 7,238 | 6,677 | $10K | |
| 73562 | 1,309 | 1,268 | $9K | |
| J1631 | Injection, haloperidol decanoate, per 50 mg | 573 | 541 | $9K |
| 86706 | 1,716 | 1,704 | $9K | |
| 97116 | 371 | 144 | $9K | |
| 90734 | 353 | 352 | $9K | |
| 92134 | 182 | 179 | $8K | |
| 90648 | 733 | 732 | $8K | |
| 73030 | 1,193 | 1,144 | $8K | |
| 92579 | 162 | 159 | $8K | |
| 99238 | Hospital discharge day management, 30 minutes or less | 113 | 112 | $8K |
| 94726 | 155 | 154 | $8K | |
| 77065 | Tomosynthesis, mammo | 100 | 95 | $8K |
| 76818 | 99 | 68 | $8K | |
| 0004A | 189 | 186 | $8K | |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | 105 | 102 | $7K |
| 90473 | 2,364 | 2,355 | $7K | |
| 82570 | 2,656 | 2,517 | $7K | |
| 99222 | Initial hospital care, per day, moderate complexity | 55 | 54 | $7K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 4,451 | 4,210 | $7K |
| 82607 | 1,103 | 1,096 | $7K | |
| 90658 | 674 | 671 | $7K | |
| 90697 | 50 | 50 | $7K | |
| 81001 | 8,429 | 8,072 | $7K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 90 | 45 | $7K |
| 82728 | 1,181 | 1,169 | $7K | |
| 84702 | 2,618 | 2,315 | $6K | |
| 92557 | 139 | 137 | $6K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1,137 | 1,035 | $6K |
| 82652 | 302 | 300 | $6K | |
| 82248 | 2,452 | 1,616 | $6K | |
| 99221 | 57 | 56 | $6K | |
| 86704 | 1,285 | 1,273 | $6K | |
| A0427 | Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | 27 | 27 | $6K |
| 72100 | 501 | 496 | $5K | |
| 86769 | 210 | 210 | $5K | |
| 82247 | 2,008 | 1,291 | $5K | |
| 90746 | 122 | 120 | $5K | |
| 94729 | 159 | 157 | $5K | |
| 99460 | 57 | 57 | $5K | |
| 73130 | 1,115 | 1,068 | $5K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 38 | 38 | $5K |
| 76000 | 92 | 86 | $4K | |
| 88262 | 84 | 84 | $4K | |
| 82746 | 823 | 819 | $4K | |
| 86762 | 485 | 480 | $4K | |
| 0071A | 104 | 104 | $4K | |
| 87077 | 1,415 | 1,375 | $4K | |
| D0230 | Intraoral - periapical each additional radiographic image | 436 | 425 | $4K |
| 84146 | 392 | 387 | $4K | |
| 01999 | 2,070 | 2,021 | $4K | |
| 73110 | 695 | 638 | $4K | |
| 87070 | 992 | 980 | $4K | |
| 95117 | 169 | 128 | $4K | |
| 90750 | 25 | 24 | $4K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 512 | 507 | $4K |
| 12011 | 13 | 13 | $4K | |
| 90700 | 559 | 559 | $4K | |
| 83970 | 117 | 115 | $3K | |
| 86708 | 619 | 615 | $3K | |
| 86140 | 1,786 | 1,754 | $3K | |
| 82043 | 804 | 801 | $3K | |
| 94060 | 24 | 24 | $3K | |
| 84156 | 1,713 | 1,581 | $3K | |
| 83540 | 1,304 | 1,290 | $3K | |
| 83550 | 1,330 | 1,319 | $3K | |
| 73590 | 763 | 722 | $3K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 52 | 48 | $3K |
| 82533 | 236 | 221 | $3K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 109 | 109 | $3K |
| 88304 | 128 | 127 | $2K | |
| 87088 | 1,312 | 1,276 | $2K | |
| 90677 | 69 | 69 | $2K | |
| 86787 | 446 | 443 | $2K | |
| 11721 | 41 | 41 | $2K | |
| 0064A | 55 | 55 | $2K | |
| 73090 | 510 | 465 | $2K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3,083 | 2,972 | $2K |
| J3490 | Unclassified drugs | 123 | 92 | $2K |
| 83735 | 7,511 | 6,300 | $2K | |
| 83001 | 204 | 200 | $2K | |
| 99462 | 52 | 36 | $2K | |
| G0009 | Administration of pneumococcal vaccine | 156 | 155 | $2K |
| 76819 | Fetal biophysical profile; without non-stress testing | 46 | 41 | $2K |
| 83615 | 784 | 677 | $2K | |
| 85651 | 1,837 | 1,799 | $2K | |
| 86255 | 591 | 567 | $2K | |
| 83690 | 4,466 | 4,336 | $2K | |
| 83002 | 174 | 169 | $2K | |
| 84403 | 124 | 120 | $2K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 12 | 12 | $2K |
| 92567 | 41 | 41 | $2K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 217 | 205 | $2K |
| 92225 | 51 | 51 | $1K | |
| 87186 | 753 | 731 | $1K | |
| 90656 | 86 | 85 | $1K | |
| 97162 | 14 | 12 | $1K | |
| 84100 | 6,848 | 5,773 | $1K | |
| 76813 | 15 | 14 | $1K | |
| 82550 | 3,970 | 3,750 | $1K | |
| 80076 | 123 | 122 | $1K | |
| 93246 | 14 | 13 | $1K | |
| 84436 | 1,213 | 1,179 | $1K | |
| 86376 | 149 | 148 | $1K | |
| 96368 | 118 | 117 | $1K | |
| 84480 | 398 | 386 | $1K | |
| 83021 | 70 | 70 | $1K | |
| 82962 | 7,811 | 6,243 | $1K | |
| 84153 | 185 | 179 | $1K | |
| 86705 | 356 | 352 | $1K | |
| 82784 | 168 | 165 | $1K | |
| G0010 | Administration of hepatitis b vaccine | 91 | 90 | $1K |
| 82947 | 6,129 | 5,932 | $1K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 57 | 26 | $987.39 |
| 86160 | 105 | 101 | $983.65 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 13 | 13 | $961.50 |
| 76536 | 15 | 15 | $880.18 | |
| 92002 | 12 | 12 | $848.94 | |
| 82950 | 225 | 224 | $846.18 | |
| 72170 | 166 | 164 | $816.10 | |
| 11720 | 12 | 12 | $798.30 | |
| 73080 | 199 | 191 | $793.15 | |
| 87081 | 522 | 517 | $761.36 | |
| D0220 | Intraoral - periapical first radiographic image | 39 | 37 | $738.67 |
| 92226 | 19 | 19 | $727.04 | |
| 73560 | 113 | 109 | $724.69 | |
| 86765 | 59 | 59 | $703.48 | |
| 82150 | 242 | 240 | $642.86 | |
| 85045 | 291 | 268 | $618.83 | |
| 86709 | 213 | 212 | $592.54 | |
| 96375 | Therapeutic injection; each additional sequential IV push | 2,523 | 2,421 | $562.04 |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | 40 | 40 | $552.84 |
| 86038 | 189 | 187 | $534.81 | |
| 0003A | 12 | 12 | $497.40 | |
| 2010F | 2,082 | 1,960 | $492.31 | |
| 86703 | 36 | 36 | $491.90 | |
| 73502 | 52 | 52 | $478.58 | |
| 76642 | 12 | 12 | $434.26 | |
| 90707 | 43 | 43 | $433.76 | |
| 4037F | 3,064 | 3,042 | $420.94 | |
| 90716 | 25 | 25 | $419.50 | |
| 3008F | 4,570 | 4,265 | $413.19 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 2,956 | 2,705 | $410.99 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 383 | 380 | $408.39 |
| 82465 | 244 | 244 | $402.53 | |
| 82977 | 118 | 116 | $402.40 | |
| 0545F | 326 | 303 | $402.40 | |
| 84484 | 3,396 | 3,177 | $364.14 | |
| 82105 | 110 | 110 | $364.00 | |
| 84550 | 172 | 150 | $317.47 | |
| 90723 | 53 | 53 | $300.92 | |
| 81511 | 14 | 14 | $300.52 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 1,319 | 1,232 | $295.00 |
| 82552 | 3,022 | 2,874 | $293.25 | |
| 77073 | 25 | 25 | $290.10 | |
| 87338 | 51 | 51 | $289.16 | |
| 73100 | 30 | 25 | $277.31 | |
| 92202 | 12 | 12 | $273.52 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 43 | 38 | $263.63 |
| 85384 | 91 | 80 | $234.47 | |
| 84402 | 26 | 25 | $223.02 | |
| 86735 | 33 | 33 | $214.01 | |
| 81508 | 12 | 12 | $197.55 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 3,418 | 3,371 | $156.89 |
| 87184 | 27 | 26 | $116.86 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 2,476 | 2,384 | $116.64 |
| 73070 | 30 | 27 | $111.56 | |
| 83520 | 13 | 13 | $108.56 | |
| 90696 | 15 | 15 | $86.92 | |
| 96367 | 12 | 12 | $62.44 | |
| 86593 | 27 | 25 | $58.56 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 1,604 | 1,504 | $57.94 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 162 | 145 | $54.39 |
| 82985 | 12 | 12 | $53.20 | |
| 86364 | 12 | 12 | $46.40 | |
| 96127 | 31 | 31 | $42.00 | |
| 84460 | 13 | 13 | $40.24 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 107 | 84 | $36.19 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 673 | 563 | $34.51 |
| 85014 | 112 | 112 | $34.00 | |
| 85018 | 113 | 113 | $34.00 | |
| 85041 | 54 | 54 | $33.82 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 1,381 | 1,340 | $33.00 |
| 73120 | 12 | 12 | $31.19 | |
| 93000 | 151 | 145 | $30.00 | |
| 87040 | 178 | 175 | $24.69 | |
| 73060 | 25 | 24 | $24.55 | |
| 81002 | 704 | 690 | $20.00 | |
| 93041 | 1,264 | 1,236 | $19.36 | |
| 3089F | 44 | 40 | $18.19 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1,471 | 1,386 | $16.16 |
| 83605 | 297 | 267 | $14.82 | |
| 83930 | 67 | 66 | $12.14 | |
| J2704 | Injection, propofol, 10 mg | 29 | 29 | $11.20 |
| 84450 | 12 | 12 | $10.06 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 399 | 392 | $9.87 |
| 73140 | 13 | 12 | $7.50 | |
| 85008 | 50 | 42 | $7.46 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 111 | 109 | $7.34 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 126 | 119 | $3.85 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 71 | 57 | $3.24 |
| J1630 | Injection, haloperidol, up to 5 mg | 557 | 511 | $2.90 |
| J1644 | Injection, heparin sodium, per 1000 units | 413 | 179 | $2.60 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 209 | 172 | $1.96 |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 271 | 240 | $1.89 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 172 | 172 | $1.75 |
| 82009 | 152 | 145 | $1.51 | |
| J2060 | Injection, lorazepam, 2 mg | 306 | 228 | $0.72 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 14 | 14 | $0.52 |
| 1034F | 633 | 553 | $0.18 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 14 | 14 | $0.08 |
| 2022F | 106 | 103 | $0.04 | |
| 3028F | 167 | 158 | $0.01 | |
| 90611 | 46 | 37 | $0.01 | |
| 99080 | 5,420 | 1,420 | $0.00 | |
| 0502F | 2,342 | 1,315 | $0.00 | |
| G8506 | Patient receiving angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy | 57 | 56 | $0.00 |
| 3511F | 228 | 224 | $0.00 | |
| 85378 | 96 | 96 | $0.00 | |
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | 1,334 | 122 | $0.00 |
| 85007 | 117 | 107 | $0.00 | |
| 3078F | 31 | 28 | $0.00 | |
| 3077F | 257 | 224 | $0.00 | |
| 76376 | 52 | 51 | $0.00 | |
| 1159F | 31 | 31 | $0.00 | |
| 2028F | 49 | 37 | $0.00 | |
| 3085F | 15 | 13 | $0.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 242 | 229 | $0.00 |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 85 | 70 | $0.00 |
| 3080F | 79 | 73 | $0.00 | |
| 3074F | 13 | 13 | $0.00 | |
| 3066F | 16 | 14 | $0.00 | |
| 73552 | 24 | 24 | $0.00 | |
| 1125F | 15 | 15 | $0.00 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 25 | 25 | $0.00 |
| 3079F | 16 | 16 | $0.00 |